267 related articles for article (PubMed ID: 9988811)
21. [Congenital toxoplasmosis retinochoroiditis after primary infection of the mother in pregnancy].
Kuchar A; Hayde M; Steinkogler FJ
Ophthalmologe; 1996 Apr; 93(2):190-3. PubMed ID: 8652987
[TBL] [Abstract][Full Text] [Related]
22. Spiramycin/cotrimoxazole versus pyrimethamine/sulfonamide and spiramycin alone for the treatment of toxoplasmosis in pregnancy.
Valentini P; Buonsenso D; Barone G; Serranti D; Calzedda R; Ceccarelli M; Speziale D; Ricci R; Masini L
J Perinatol; 2015 Feb; 35(2):90-4. PubMed ID: 25211284
[TBL] [Abstract][Full Text] [Related]
23. Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres.
Gras L; Wallon M; Pollak A; Cortina-Borja M; Evengard B; Hayde M; Petersen E; Gilbert R;
Acta Paediatr; 2005 Dec; 94(12):1721-31. PubMed ID: 16421031
[TBL] [Abstract][Full Text] [Related]
24. Prevention of congenital toxoplasmosis in Slovenia by serological screening of pregnant women.
Logar J; Petrovec M; Novak-Antolic Z; Premru-Srsen T; Cizman M; Arnez M; Kraut A
Scand J Infect Dis; 2002; 34(3):201-4. PubMed ID: 12030394
[TBL] [Abstract][Full Text] [Related]
25. Congenital toxoplasmosis: therapeutic strategies.
Foulon W
Arch Pediatr; 2003 Feb; 10 Suppl 1():10-1. PubMed ID: 12802954
[No Abstract] [Full Text] [Related]
26. [Congenital toxoplasmosis: prevention in the pregnant woman and management of the neonate].
Pelloux H; Fricker-Hidalgo H; Pons JC; Bost-Bru C; Brenier-Pinchart MP; Jouk PS; Ambroise-Thomas P
Arch Pediatr; 2002 Feb; 9(2):206-12. PubMed ID: 11915504
[TBL] [Abstract][Full Text] [Related]
27. Treatment of toxoplasmosis in pregnancy: concentrations of spiramycin and neospiramycin in maternal serum and amniotic fluid.
Gratzl R; Sodeck G; Platzer P; Jäger W; Graf J; Pollak A; Thalhammer T
Eur J Clin Microbiol Infect Dis; 2002 Jan; 21(1):12-6. PubMed ID: 11913495
[TBL] [Abstract][Full Text] [Related]
28. [The prevalence of Toxoplasma gondii infection among 2016 pregnant women and their children in the Institute of Mother and Child in Warsaw].
Niemiec KT; Raczyński P; Markiewicz K; Leibschang J; Ceran A
Wiad Parazytol; 2002; 48(3):293-9. PubMed ID: 16888975
[TBL] [Abstract][Full Text] [Related]
29. [Toxoplasmosis in sick persons].
Netrebko ID
Lik Sprava; 2002; (8):90-3. PubMed ID: 12669554
[TBL] [Abstract][Full Text] [Related]
30. Too late prenatal diagnosis of fetal toxoplasmosis: a case report.
Nowakowska D; Respondek-Liberska M; Golab E; Stray-Pedersen B; Szaflik K; Dzbenski TH; Wilczynski J
Fetal Diagn Ther; 2005; 20(3):190-3. PubMed ID: 15824496
[TBL] [Abstract][Full Text] [Related]
31. Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment.
Hohlfeld P; Daffos F; Thulliez P; Aufrant C; Couvreur J; MacAleese J; Descombey D; Forestier F
J Pediatr; 1989 Nov; 115(5 Pt 1):765-9. PubMed ID: 2681638
[TBL] [Abstract][Full Text] [Related]
32. Toxoplasmosis screening during pregnancy in France: Opinion of an expert panel for the CNGOF.
Picone O; Fuchs F; Benoist G; Binquet C; Kieffer F; Wallon M; Wehbe K; Mandelbrot L; Villena I
J Gynecol Obstet Hum Reprod; 2020 Sep; 49(7):101814. PubMed ID: 32428782
[TBL] [Abstract][Full Text] [Related]
33. Ophthalmic outcomes after prenatal and postnatal treatment of congenital toxoplasmosis.
Brézin AP; Thulliez P; Couvreur J; Nobré R; Mcleod R; Mets MB
Am J Ophthalmol; 2003 Jun; 135(6):779-84. PubMed ID: 12788116
[TBL] [Abstract][Full Text] [Related]
34. Toxoplasmosis in the fetus and newborn: an update on prevalence, diagnosis and treatment.
Moncada PA; Montoya JG
Expert Rev Anti Infect Ther; 2012 Jul; 10(7):815-28. PubMed ID: 22943404
[TBL] [Abstract][Full Text] [Related]
35. Profile of pregnant women and children treated at a reference center for congenital toxoplasmosis in the northern state of Minas Gerais, Brazil.
Soares JA; Carvalho SF; Caldeira AP
Rev Soc Bras Med Trop; 2012 Feb; 45(1):55-9. PubMed ID: 22370829
[TBL] [Abstract][Full Text] [Related]
36. Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy.
Wallon M; Liou C; Garner P; Peyron F
BMJ; 1999 Jun; 318(7197):1511-4. PubMed ID: 10356003
[TBL] [Abstract][Full Text] [Related]
37. [Suspected toxoplasmosis in pregnancy].
Ørbæk M; Kjær ASL; Nielsen HV; Lebech M; Katzenstein T; Lebech AM
Ugeskr Laeger; 2020 Apr; 182(18):. PubMed ID: 32400373
[TBL] [Abstract][Full Text] [Related]
38. Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis.
Gras L; Gilbert RE; Ades AE; Dunn DT
Int J Epidemiol; 2001 Dec; 30(6):1309-13. PubMed ID: 11821335
[TBL] [Abstract][Full Text] [Related]
39. Toxoplasmosis: diagnosis, treatment, and prevention in congenitally exposed infants.
Kaye A
J Pediatr Health Care; 2011; 25(6):355-64. PubMed ID: 22018426
[TBL] [Abstract][Full Text] [Related]
40. Azithromycin inhibits vertical transmission of Toxoplasma gondii in Calomys callosus (Rodentia: Cricetidae).
Costa IN; Angeloni MB; Santana LA; Barbosa BF; Silva MC; Rodrigues AA; Rostkowsa C; Magalhães PM; Pena JD; Silva DA; Mineo JR; Ferro EA
Placenta; 2009 Oct; 30(10):884-90. PubMed ID: 19703714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
